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1980ties: shift from abstinence towards harm reduction, and from psychosocial approach towards medical approach (Frank et al., 2013) Treatment for illicit DUD, including OUD publically funded -must be initiated within two weeks Treatment for OUD secondary to pain treatment managed in general healthcare system (The Danish Health Authority, 2017) Hospital pharmacies deliver medication to clinics, and intake should be under clinical supervision 5 days per week/as take-home medication, depending on level of functioning (The Danish Health Authority, 2017) At enrollment, patients are referred to relevant type of treatment (methadone/buprenorphine) Medication record is linked to the prescribing physician, rather than to the individual patient 
LIMITATIONS
Registers are only as good as the data that were put into them Some questions at enrollment are optimal (e.g. past year use) Some treatment episodes have missing information and leave open whether patients were in treatment at time at risk (e.g. dates of discharge) No access to contributing causes of death lead to conservative estimate of fatal overdoses No access to non-fatal overdoses handled by paramedics or leading to medical care Definitions of fatal overdoses, handling of the deceased, and coding of information varies between regions and time Diagnostic codes vary in terms of specificity and sensitivity in relation to overdoses (X42 will almost always indicate that the death was due to accidental overdose, whereas Y12, F11 or F19 involve uncertainty Risk factors may differ for later cohorts, but were consistent recent literature
